Is uremic cardiomyopathy a direct consequence of chronic kidney disease?

Expert Review of Cardiovascular Therapy

Volumn 12, Issue 2, 2014, Pages 127-130

  Chinnappa, Shanmugakumar ^a,b   Hothi, Sandeep S ^c,e   Tan, Lip Bun ^a,d  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d LEEDS GENERAL INFIRMARY   (United Kingdom)

^e GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

cardiac reserve; chronic kidney disease; heart failure; uremic cardiomyopathy

Indexed keywords

CARDIOMYOPATHY; CARDIORENAL SYNDROME; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CHRONIC KIDNEY DISEASE; ECHOCARDIOGRAPHY; FUNCTIONAL ASSESSMENT; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART PERFORMANCE; HUMAN; MORBIDITY; PATHOPHYSIOLOGY; REVIEW; UREMIA; UREMIC CARDIOMYOPATHY;

CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; EXERCISE TEST; HEART FAILURE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; UREMIA;

EID: 84893155454     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2014.879040     Document Type: Review

References (25)

1. Annual Data Report 2013. US Renal Data System. Available from: www.usrds.org/atlas. aspx [Last accessed December 2013]
2. Dhingra R, Gaziano JM, Djousse L. Chronic kidney disease and the risk of heart failure in men. Circ Heart Fail 2011;4(2): 138-44
3. Remppis A, Ritz E. Cardiac problems in the dialysis patient: beyond coronary disease. Semin Dial 2008;21(4):319-25
4. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 2013;382(9889): 339-52
5. Herzog CA, Asinger RW, Berger AK, et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: improving Global Outcomes (KDIGO). Kidney Int 2011;80(6): 572-86
6. Ronco C, McCullough P, Anker SD, et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J 2010;31(6): 703-11
7. Park M, Hsu CY, Li Y, et al. Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol 2012;23(10):1725-34
8. Mark PB, Johnston N, Groenning BA, et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int 2006;69(10):1839-45
9. Amann K, Breitbach M, Ritz E, Mall G. Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 1998; 9(6):1018-22
10. Aurigemma GP, Silver KH, Priest MA, Gaasch WH. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol 1995;26(1):195-202
11. Cotter G, Williams SG, Vered Z, Tan LB. Role of cardiac power in heart failure. Curr Opin Cardiol 2003;18(3):215-22
12. Douglas PS, Khandheria B, Stainback RF, et al. ACCF/ASE/ACEP/AHA/ASNC/ SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine. J Am Coll Cardiol 2008;51(11). 1127-47
13. Mitsnefes MM, Kimball TR, Witt SA, et al. Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation 2003; 107(6):864-8
14. Weaver DJ Jr, Kimball TR, Knilans T, et al. Decreased maximal aerobic capacity in pediatric chronic kidney disease. J Am Soc Nephrol 2008;19(3):624-30
15. Sietsema KE, Amato A, Adler SG, Brass EP. Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease. Kidney Int 2004;65(2):719-24
16. Sietsema KE, Hiatt WR, Esler A, et al. Clinical and demographic predictors of exercise capacity in end-stage renal disease. Am J Kidney Dis 2002;39(1):76-85
17. Goldspink DF, Burniston JG, Tan LB. Cardiomyocyte death and the ageing and failing heart. Exp Physiol 2003;88(3): 447-58
18. Tan LB. Cardiac pumping capability and prognosis in heart failure. Lancet 1986; 2(8520):1360-3
19. Williams SG, Cooke GA, Wright DJ, et al. Peak exercise cardiac power output; a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J 2001;22(16):1496-503
20. Schlaich MP, Socratous F, Hennebry S, et al. Sympathetic activation in chronic renal failure. J Am Soc Nephrol 2009;20(5): 933-9
21. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002;62(5):1524-38
22. Lekawanvijit S, Adrahtas A, Kelly DJ, et al. Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? Eur Heart J 2010;31(14): 1771-9
23. Periyasamy SM, Chen J, Cooney D, et al. Effects of uremic serum on isolated cardiac myocyte calcium cycling and contractile function. Kidney Int 2001;60(6):2367-76
24. Raine AE, Seymour AM, Roberts AF, et al. Impairment of cardiac function and energetics in experimental renal failure. J Clin Invest 1993;92(6):2934-40
25. Chinnappa S, Mooney A, Lewis NT, et al. New evidence of cardiac dysfunction associated with renal impairment. Int J Cardiol 2011;152(3):411-13